SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-022213
Filing Date
2019-11-06
Accepted
2019-11-06 16:33:03
Documents
14
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k0110619_nektarthera.htm   iXBRL 8-K 32759
2 PRESS RELEASE TITLED "NEKTAR THERAPEUTICS REPORTS FINANCIAL RESULTS FOR THE THIR f8k080819ex99-1_nektar.htm EX-99.1 119575
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2824
  Complete submission text file 0001213900-19-022213.txt   345427

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nktr-20191106.xsd EX-101.SCH 3170
5 XBRL LABEL FILE nktr-20191106_lab.xml EX-101.LAB 34581
6 XBRL PRESENTATION FILE nktr-20191106_pre.xml EX-101.PRE 22696
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k0110619_nektarthera_htm.xml XML 3501
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 191196810
SIC: 2834 Pharmaceutical Preparations